VaccinesNews.net

Vaccines Xagena

Search results for "Gardasil"

Gardasil ( quadrivalent human papillomavirus types 6, 11, 16, 18, recombinant vaccine ), an investigational vaccine, prevented 100 percent of high-grade cervical pre-cancers and non-invasive cervical ...


The FDA ( U.S. Food and Drug Administration ) has approved Gardasil, the first vaccine developed to prevent cervical cancer, precancerous genital lesions and genital warts due to human papillomavirus ...


The FDA ( Food and Drug Administration ) has approved Gardasil, the first vaccine developed to prevent cervical cancer, precancerous genital lesions and genital warts due to human papillomavirus ( HPV ...


On June 8th 2006, the FDA ( Food and Drug Administration ) announced the approval of Gardasil, and on June 29th the Advisory Committee on Immunizations Practices ( ACIP ) voted to recommend adding Gar ...


In a commentary published in the Canadian Medical Association Journal ( CMAJ ), Abby Lippman, an epidemiologist at McGill University in Montreal, Canada, and colleagues wrote that there is no urgent n ...


Researchers have reported that women who are positive for HPV DNA, do not benefit from Cervarix, a vaccine against HPV 16/18 L1 virus-like particle. HPV is the sole cause of cervical cancer, and ty ...


The National Vaccine Information Center ( NVIC ) issued a new report on HPV vaccine ( Gardasil ) safety analyzing adverse event reports to the federal Vaccine Adverse Event Reporting System ( VAERS ). ...


HPV infection is necessary for the development of cervical cancer and the vaccine may prevent primary infection with HPV types 16 and 18. However, Abby Lippman, chair of the Canadian Women's Health N ...


The EMEA ( European Medicines Agency ) has received reports of deaths in women who had previously received Gardasil, including two reports concerning the sudden and unexpected deaths of two young wome ...


The FDA ( Food and Drug Administration ) has approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus ( HPV ) types 6, 11, 16, an ...


Merck & Co has announced that in the pivotal phase III efficacy study, its investigational 9-valent HPV vaccine ( V503 ) prevented approximately 97% of cervical, vaginal and vulvar pre-cancers cau ...